Search results
Author(s):
Stephan Baldus
Added:
1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,…
View more
Author(s):
Volker Rudolph
,
Stephan Baldus
Added:
1 year ago
ESC Congress 2024 — TEER non-inferior to mitral valve surgery with regard to death, HF rehospitalisation, stroke, reintervention of LVAD at one year.Dr Volker Rudolph (Heart and Diabetes Center NRW, DE) and Prof Stephan Baldus (University Hospital of Köln, DE) joins us in London to discuss the MATTERHORN trial (NCT02371512; University Hospital of Köln).This multicenter, randomized controlled…
View more
Author(s):
David J Cohen
Added:
2 months ago
TCT 2025 - The PREVUE-VALVE study finds an 8.2% prevalence of moderate or greater valvular heart disease amongst Americans age 65-85, increasing to 18.4% when participants with mild to moderate VHD were included.Dr David J. Cohen (Cardiovascular Research Foundation & St Francis Hospital, US) joins us to discuss findings from the PREVUE-VALVE study, examining age and sex-specific prevalence of…
View more
Author(s):
Rania Hammami
,
Uthman Aluthman
Added:
8 months ago
TCT Middle East 2025 — We are joined by Prof Rania Hammami and Dr Uthman Aluthman as they discuss the key takeaways for minimally invasive surgery from the conference.The specialists provide insights on evolving definitions and expanding applications of minimally invasive cardiac surgical techniques. They address practical considerations regarding patient selection, recovery trajectories, and…
View more
Author(s):
Thomas Modine
Added:
8 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Author(s):
Devi Nair
,
Laurence Epstein
,
Robert D Schaller
Added:
3 months ago
In this essential episode of Rhythm Interventions Unplugged, host Dr Devi Nair (St. Bernard's Medical Center, US) sits down with two leading experts in cardiac device management: Dr Larry Epstein and Dr Robert Schaller. Together, they explore a critical challenge facing electrophysiologists today - managing pacemaker and ICD leads in patients requiring tricuspid valve interventions.Dr Epstein and…
View more
Atrioventricular (AV) Valves Summit 2024
Video Series
NY Valves 2025 Late-Breaking Science Collection
Video Series
Author(s):
Added:
6 months ago
New York Valves 25 - A substudy of TRISCEND II investigating the effect of transcatheter tricuspid valve replacement (TTVR) on preference-weighted health status showed significant benefits in patients who received TTVR.We are joined by Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, US) to discuss the findings from a substudy of the TRISCEND II trial, which aimed to create an…
View more
Author(s):
Yu Mao
,
Fengkai Liu
,
Xi Chen
,
et al
Added:
2 months ago